Atlas Trials

Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy

Clinical trial NCT03212755 · UNKNOWN

Trial details

NCT number
NCT03212755
Sponsor
Assiut University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetic Nephropathies
Start date
2017-08-01
Primary completion
2019-06-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.